Amedica (AMDA) Reports Q3 Loss of $0.30
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Amedica (NASDAQ: AMDA) reported Q3 EPS of ($0.30), versus ($2.21) reported last year. Revenue for the quarter came in at $3.38 million, versus $4.84 million reported last year.
For earnings history and earnings-related data on Amedica (AMDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Credit Suisse Downgrades Himax Technologies (HIMX) to Neutral
- Kingtone Wirelessinfo (KONE) Reports Q3 Loss of $0.11
- Eli Lilly (LLY) to Acquire CoLucid Pharmaceuticals (CLCD) for $960M
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!